DKDaniel KuritzkesMDVideoHIVViral Hepatitis and Liver DiseaseAPACC 2017New HIV drugs / regimens | Daniel Kuritzkes, MDView Video
MCMartin ChooMMedSc PHVideoHIVViral Hepatitis and Liver DiseaseAPACC 2017Barriers to access - Community perspective | Martin Choo, MMedScView Video
GKGiten KhwairakpamVideoHIVViral Hepatitis and Liver DiseaseAPACC 2017Access to treatment/care on the country level | Giten KhwairakpamView Video
MHMargaret HellardAM, MBBS, FRACP, FAFPHM, PhDVideoHIVViral Hepatitis and Liver DiseaseAPACC 2017Access to treatment/care on the global level | Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhDView Video
CHChien-Ching HungMD, PhDVideoHIVViral Hepatitis and Liver DiseaseAPACC 2017Clinical Case presentation | Chien-Ching Hung, MD, PhDView Video
CHChien-Ching HungMD, PhDVideoHIVViral Hepatitis and Liver DiseaseAPACC 2017The SWORD study | Chien-Ching Hung, MD, PhDView Video
DKDaniel KuritzkesMDVideoHIVViral Hepatitis and Liver DiseaseAPACC 2017Does resistance still matter? | Daniel Kuritzkes, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseAPACC 2017Neurocognitive issues among aging adults | Edwina WrightView Video
RRReena RajasuriarMPharm, PhDVideoHIVViral Hepatitis and Liver DiseaseAPACC 2017Aging among adults in the context of HIV | Reena Rajasuriar, MPharm, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseAPACC 2017Mental health and neurocognitive issues related to adolescents who have grown up with HIV | Warren Y.K. NGView Video
MBMark BoydBA, BM, BS, DCTH&H, MHID, MD, FRACPVideoHIVViral Hepatitis and Liver DiseaseAPACC 2017ART: are two drugs enough? | Mark Boyd, BA, BM, BS, DCTH&H, MHID, MD, FRACPView Video
MCMartin ChooMMedSc PHVideoHIVViral Hepatitis and Liver DiseaseAPACC 2017Community Perspective | Martin Choo, MMedScView Video
